|
Please join us this Thursday, January 18th at noon to learn how to navigate our new system to submit temperature logs and temperature excursion information in REDcap. This training will be similar to the November session, but a good refresher with some new information too!
Topic: REDCap Refresher - Submitting Temperature Logs and Reporting Temperature Excursions
Date: January 18, 2024
Time: 12 noon
Intended Audience: Providers and Vaccine Coordinators for the Childhood Vaccine Program
Join the Training Session
Webinar ID: 851 4240 2545
Passcode: 673609
Nirsevimab:
Additional doses of nirsevimab remain available for ordering. All providers should have the RSV order set available in the IIS and have the ability to place orders. Order cut off is 11:00am on Wednesday for review and approval each week. Ordering will remain open so long as product is available. Use the vaccine advertisement tool in the WAIIS to advertise doses you aren't using, or to search for available doses for transfer. Find directions on using the tool here.
Abrysvo:
Abrysvo is the RSV product available for pregnant teens between 32-36 weeks gestation during this RSV season. This product is limited and available to order in your routine childhood order sets. Please keep in mind that any order for this product should include a comment to demonstrate the need for this product. We request that this product only be ordered if you have an eligible patient in need of this vaccine, it is not required to be ordered by every clinic.
When you upload your monthly temperature logs in REDCap, please be sure to only include the temperature logs for each individual unit. If you have your temperature logs scanned as a single file (i.e., fridge and freezer combined), you will need to separate them so they can be uploaded to the correct storage unit. This allows your Provider Support Specialist to quickly review the temperature logs for each individual unit. Thank you!
Thank you to everyone for submitting your December temperature logs in REDCap. As a reminder, most providers will still need to submit monthly paper temperature logs unless they meet the CDC/Childhood Vaccine Program (CVP) reporting requirements outlined below for submitting monthly, digital temperature summary reports. The CDC/CVP requires that reports include staff initials for the daily min/max temperature check, showing that a manual audit of vaccine temperatures was performed. Most providers find that their system is unable to generate reports with staff initials included. If you previously submitted temperature summary reports for the COVID-19 program, you will need to meet the more stringent CDC/CVP requirements and have your reports pre-approved. Providers whose digital data logger (DDL) or temperature monitoring system (TMS) reports do not meet the reporting requirements must continue to submit monthly paper temperature logs in REDCap. Please refer to the Temperature Reporting Guide for more information.
Providers wishing to obtain program approval must submit a copy of their report to WAChildhoodVaccines@doh.wa.gov for review. To be considered for approval, DDL and TMS summary reports must contain the following as required by CDC’s Vaccines for Children Program.
- Min/max temperature check once per day
- Time and date of reading
- Name or initials of staff member who recorded the reading.
A Single Sign-On (SSO) process will be implemented in the first quarter of 2024 to improve accessibility and ease of login to the IIS. IIS users will no longer be required to manually login to the IIS each time they access the system. IIS users will need to establish a Single Sign-On (SSO) link initially between SAW and their IIS user account. Instructions can be found here. Click here for guidance on creating SAW accounts.
Contact the IIS Help Desk at 1-800-325-5599 or WAIISHelpDesk@doh.wa.gov for assistance with your IIS user account. Click ‘GET HELP’ on the SecureAccess Washington login page for SAW account support.
This message is to inform you of the FluMist Replacement Program for product ordered through the Childhood Vaccine Program. The Replacement Program allows for the replacement of unused, expiring FluMist doses, at no cost, to help you maximize product usage opportunities. AstraZeneca has contracted with McKesson Specialty Health (MSH) for implementation of this Replacement Program. This contract is between AstraZeneca and McKesson.
If providers would like to take advantage of this replacement program, they can contact the AstraZeneca Replacement Program by phone or by email, as detailed in the instructions found in the flyer.
Eligibility Guidelines are described below, and requests for replacements can be made between Monday, December 4 and Wednesday, January 31.
- Doses must have been ordered through the Childhood Vaccine Program. Private doses are not eligible for the FluMist® Quadrivalent Replacement Program for CDC.
- Product expiration date must be on or before February 2, 2024.
- AstraZeneca will replace expired doses of FluMist® Quadrivalent while supplies last.
For questions about this program, please contact the FluMist® Quadrivalent Replacement Program for CDC at 1-877-633-7375 or flumistreplacement@mckesson.com.
Important Dates to Remember:
|
Monday December 4, 2023
|
First day to make replacement request
|
|
No more than 15 days prior to the expiration date
|
Request to replace expiring doses can be made
|
|
Wednesday January 31, 2024
|
Last day to make replacement request
|
|
Thursday February 15, 2024
|
All expired doses must be received at MSH Distribution Center for replacement
|
|
